September 19, 2024

GHBellaVista

Imagination at work

HIMSSCast: The future of telehealth reimbursement

Restrictions and uncertainty around telehealth reimbursement have always been an impediment to adoption. In the course of the COVID-19 emergency, that stress was eased relatively, but now the new normal is commencing to get form. What limitations nonetheless continue being to telehealth reimbursement, and how might they be overcome? To solution that problem, host Jonah Comstock and Health care Finance News Taking care of Editor Susan Morse welcome McKinsey & Corporation partners Oleg Bestsennyy and Gunjan Khanna.

This episode is introduced to you by BlueJeans.

Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Play!

 

Chatting points:

  • COVID-19 reimbursement variations and which of them will stick around
  • Adoption lessons learned and how they’ll impact reimbursement coverage
  • Holistic tele-treatment and treatment further than the movie go to
  • Affect of new entrants and innovation on the area
  • Is payment-for-service reimbursement an innovation blocker?
  • Reimbursement for various telehealth modalities
  • Time to lead somewhat than follow for private payers?
  • The nonetheless-unresolved problem of induced utilization
  • The increase of value-dependent treatment and hybrid treatment versions
  • Telehealth reimbursement and overall health fairness
  • How are individuals experience about telehealth now?
  • Closing feelings: the upcoming of telehealth reimbursement

A lot more about this episode:

Report reveals ‘vast improvement’ in condition telehealth reimbursement procedures

COVID-19 could forever alter the telehealth landscape, from reimbursement to utilization

Telehealth reimbursement parity spurs insurer problems of overutilization

CMS will reimburse for 11 new telehealth solutions during the community overall health emergency

Congressional motion is necessary for telehealth not to return to a rural gain, Seema Verma says

Telehealth: A quarter-trillion-greenback publish-COVID-19 truth? (McKinsey)

COVID-19 Shopper Health care Insights: What 2021 could hold (McKinsey)

How COVID-19 has transformed the way US customers consider about healthcare (McKinsey)